BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27163762)

  • 1. Nephrology Update: End-Stage Renal Disease and Renal Replacement Therapy.
    Desai N; Rahman M
    FP Essent; 2016 May; 444():23-9. PubMed ID: 27163762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of primary care issues common to CKD and ESRD patients: a brief primer for the nephrology provider.
    Chettiar A
    Adv Chronic Kidney Dis; 2014 Jul; 21(4):371-6. PubMed ID: 24969390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ten-year experience in renal replacement therapy in children. A report from Dialysis Center, Department of Pediatric Nephrology, Children's University Hospital in Lublin].
    Zajaczkowska M; Kołłataj B; Bieniaś B; Wieczorkiewicz-Płaza A; Borzecka H; Sikora P; Majewski M
    Przegl Lek; 2006; 63 Suppl 3():162-5. PubMed ID: 16898520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'?
    Perl J; Unruh ML; Chan CT
    Kidney Int; 2006 Nov; 70(10):1687-93. PubMed ID: 16969388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.
    Mehrotra R; Marsh D; Vonesh E; Peters V; Nissenson A
    Kidney Int; 2005 Jul; 68(1):378-90. PubMed ID: 15954930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease and its management in older adults.
    Winchester JF; Rakowski TA
    Clin Geriatr Med; 1998 May; 14(2):255-65. PubMed ID: 9536104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ideal timing and predialysis nephrology care duration for dialysis initiation: from analysis of Japanese dialysis initiation survey.
    Yamagata K; Nakai S; Masakane I; Hanafusa N; Iseki K; Tsubakihara Y;
    Ther Apher Dial; 2012 Feb; 16(1):54-62. PubMed ID: 22248196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
    Friedlander MA; Hricik DE
    Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in renal replacement therapy.
    Gadegbeku C; Freeman M; Agodoa L
    J Natl Med Assoc; 2002 Aug; 94(8 Suppl):45S-54S. PubMed ID: 12152912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland.
    Helanterä I; Haapio M; Koskinen P; Grönhagen-Riska C; Finne P
    Am J Kidney Dis; 2012 May; 59(5):700-6. PubMed ID: 21958597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of nephrology and renal replacement therapy in Korea.
    Lee HB
    J Nephrol; 2011; 24 Suppl 17():S93-6. PubMed ID: 21614787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of impeding factors for dry weight achievement in end-stage renal disease after appropriate kidney graft function.
    Rivera-González SC; Pérez-Grovas H; Madero M; Mora-Bravo F; Saavedra N; López-Rodriguez J; Lerma C
    Artif Organs; 2014 Feb; 38(2):113-20. PubMed ID: 23889479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Disease: End-Stage Renal Disease.
    Braun MM; Khayat M
    FP Essent; 2021 Oct; 509():26-32. PubMed ID: 34643362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.